Slide 1

EARLY PHASE

Slide 1
Slide 1

EARLY PHASE

Slide 1
previous arrowprevious arrow
next arrownext arrow

FIELDS OF RESEARCH

REACHING OUT IS EASY AND FAST – LET’S TALK

Prof. Dr. Thomas Forst

Chairman of the Executive Board
located at CRS Mannheim

LET’S TALK SCIENCE

Pharmacokinetic interactions between simvastatin and setipiprant, a CRTH2 antagonist.

Science

Effect of faldaprevir on raltegravir pharmacokinetics in healthy volunteers.

Science

Inter- and intrasubject variability of the inflammatory response to segmental endotoxin challenge in healthy volunteers.

Science

Evaluation of the effect of food and age on the pharmacokinetics of oral netupitant and palonosetron in healthy subjects: A randomized, open-label, crossover phase 1 study.

Science
read more in our blog
CRO Leadership Awards 2019

CRS is proud to be recognised again by pharma companies worldwide as a leading CRO with regard to: capabilities, compatibility, quality and reliability.

European Biotechnology Guide

Find CRS’s company profile in the European Biotechnology Science Industry Guide, volume 9 2019.

EcoVadis – CSR Rating

Based on the CSR rating by EcoVadis in 2022 CRS has been granted Silver Recognition Level.